Cases 61 - 70 of 129
UCB, Inc. et al v. Annora Pharma Private Limited et al
as 1:2020cv00987
Defendant:
Aurobindo Pharma USA Inc., Lupin Ltd., Apotex Corp. and others
Plaintiff:
UCB Biopharma SRL and UCB, Inc.
Cause Of Action: 35 U.S.C. § 271
Cephalon, Inc. v. Aurobindo Pharma, Ltd. et al
as 1:2020cv00962
Defendant:
Aurobindo Pharma USA, Inc., Aurobindo Pharma, Ltd. and Eugia Pharma Specialities Ltd.
Plaintiff:
Cephalon, Inc.
Cause Of Action: 35 U.S.C. § 271
Teva Pharmaceuticals International GmbH et al v. Aurobindo Pharma, Ltd. et al
as 1:2020cv00632
Plaintiff:
Teva Pharmaceuticals International GmbH, Eagle Pharmaceuticals, Inc. and Cephalon, Inc.
Defendant:
Aurobindo Pharma, Ltd., Aurobindo Pharma USA, Inc. and Eugia Pharma Specialities Ltd.
Cause Of Action: 35 U.S.C. § 271
In re: Palbociclib Patent Litigation
as 1:2019md02912
Not Classified By Court:
Aizant Drug Research Solutions Pvt. Ltd., Hetero USA Inc., Teva Pharmaceuticals USA, Inc. and others
In Re:
In re: Palbociclib Patent Litigation
Cause Of Action: 35 U.S.C. § 271
Allergan USA, Inc. et al v. Sun Pharmaceutical Industries Limited et al
as 1:2019cv02317
Plaintiff:
Allergan USA, Inc., Allergan Sales, LLC, Forest Laboratories Holdings Limited and others
Defendant:
Sun Pharmaceutical Industries Limited, Cadila Healthcare Limited, Aurobindo Pharma USA, Inc. and others
Cause Of Action: 35 U.S.C. § 271
Taiho Pharmaceutical Co., Ltd. et al v. Eugia Pharma Specialities Ltd. et al
as 1:2019cv02309
Plaintiff:
Taiho Oncology, Inc. and Taiho Pharmaceutical Co., Ltd.
Defendant:
Aurobindo Pharma U.S.A., Inc., Eugia Pharma Specialities Ltd. and Aurobindo Pharma Ltd.
Cause Of Action: 35 U.S.C. § 271
Aziende Chimiche Riunite Angelini Francesco ACRAFSpA v. Aurobindo Pharma USA Inc.
as 1:2019cv02197
Defendant:
Aurobindo Pharma USA Inc.
Plaintiff:
Aziende Chimiche Riunite Angelini Francesco ACRAFSpA
Cause Of Action: 35 U.S.C. § 271
In re: Kerydin (Tavaborole) Topical Solution 5% Patent Litigation
as 1:2019md02884
Counter Claimant:
Glasshouse Pharmaceuticals Limited Canada
Not Classified By Court:
Taro Pharmaceuticals U.S.A., Inc., Aurobindo Pharma Limited, Zydus Pharmaceuticals (USA) Inc. and others
In Re:
Kerydin (Tavaborole) Topical Solution 5% Patent Litigation
Counter Defendant:
Anacor Pharmaceuticals, Inc.
Cause Of Action: 35 U.S.C. § 271
AstraZeneca AB et al v. Aurobindo Pharma USA Inc.
as 1:2019cv02113
Defendant:
Aurobindo Pharma USA Inc.
Plaintiff:
AstraZeneca Pharmaceuticals LP, AstraZeneca AB and Nektar Therapeutics
Cause Of Action: 35 U.S.C. § 271
Novartis Pharmaceuticals Corporation v. Alkem Laboratories Ltd. et al
as 1:2019cv01979
Defendant:
Teva Pharmaceuticals USA, Inc., Aurobindo Pharma USA Inc., Lupin Inc. and others
Plaintiff:
Novartis Pharmaceuticals Corporation
Cause Of Action: 35 U.S.C. § 271
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
